Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02274025 |
Date of registration:
|
14/10/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
NovellusDx Functional Profiling of Oncogenic Mutations in Lung Cancer Patients
|
Scientific title:
|
Collection of Lung Malignant Tissue for the Validation of a Novel Technology to Identify Oncogenic Mutations and Personalized Medicine |
Date of first enrolment:
|
October 2014 |
Target sample size:
|
20 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02274025 |
Study type:
|
Observational [Patient Registry] |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Israel
| | | | | | | |
Contacts
|
Name:
|
Mordechai Kremer, Prof |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Rabin Medical Center, Beilinson |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients that are suspected to have lung cancer and are eligible for biopsy, surgical
intervention or pleural fluid suction
Exclusion Criteria:
- Patients without lung cancer
Age minimum:
18 Years
Age maximum:
85 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Lung Cancer
|
Primary Outcome(s)
|
Correct identification of tumor mutant genes
[Time Frame: up to 12 months]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|